Association of Serum Sodium, Potassium and High-Sensitivity C-Reactive Protein Levels With Mitral Regurgitation and Risk Factors in Patients With Acute Coronary Syndrome
Abstract
Acute coronary syndrome (ACS) is a condition that manifests itself when there is a reduction in the amount of blood that flows to the coronary arteries. This can lead to damage to the heart muscle or possibly death of the heart muscle. The study was conducted with the intention of determining whether there were any alterations in the levels of sodium, potassium, and high-sensitivity C-reactive protein that were found in the serum of individuals who were diagnosed with acute coronary syndrome (ACS). In addition, the objective of this study was to evaluate the relationship between these levels and risk factors such as quitting smoking, having dyslipidemia, being overweight, and having mitral regurgitation. The study had a total of 133 participants, with 83 patients being assigned to the study group and 50 individuals being assigned to the control group. A specific group of people who had recently been diagnosed with ACS made comprised the members of the study group. Both groups' blood samples were taken and then flame photometry using the Bio-Lab Diagnostic kit was used to determine the levels of serum electrolytes (Na+ and K+). Furthermore, calorimetry was utilized in order to estimate the levels of the lipid profile. The levels of sodium, C-reactive protein, and potassium in the serum were shown to have significantly increased across all age groups when compared to the control group. Despite the fact that the female group had slightly higher mean±standard deviation values of serum sodium, potassium, and C-reactive protein concentrations compared to the male group, this difference did not meet the criteria for statistical significance. When comparing the mean±standard deviation levels of serum sodium, potassium, and C-reactive protein in the presence or absence of dyslipidemia, smoking, or obesity, the results of the T-tests revealed that there were no significant differences. There was a correlation between the severity of mitral regurgitation and the mean±standard deviation values of serum sodium, potassium, and C-reactive protein concentrations. The early evaluation of serum electrolyte levels is not only necessary for appropriate replenishment but also has the potential to assist in the diagnosis of acute coronary syndrome. C-reactive protein has been shown to be associated with the development of acute coronary syndrome. and we have also demonstrated that it has the potential to serve as a biomarker for both the risk and severity of ACS. It is possible to determine the severity of mitral regurgitation by observing the elevated levels of C-reactive protein, sodium and potassium in the serum.
2. Daily ZA, Al-Ghurabei BH, Al-Qarakhli AMA, Moseley R. MicroRNA‐155 (miR-155) as an accurate biomarker of periodontal status and coronary heart disease severity: a case–control study. BMC Oral Health 2023;23:868.
3. Azizi Dargahlou S, Iriti M, Pouresmaeil M, Goh LPW. MicroRNAs; their therapeutic and biomarker properties. Cell Mol Biomed Rep 2023;3:73-88.
4. Ali Daily Z, Al-Ghurabi BH, Al-Qarakhli AMA, Hussein HM. Association Between AIM2 and Pycard Genes Polymorphisms and Susceptibility to Periodontitis with Coronary Heart Disease. Clin Cosmet Investig Dent 2023;2023:307-20.
5. Ablij HC, Meinders AE. C-reactive protein: history and revival. Eur J Intern Med 2002;13:412-22.
6. Al-Ghurabei BH. Evaluation of serum anti-cardiolipin antibody, hs-CRP and IL-6 levels in chronic periodontitis as possible risk factors for cardiovascular diseases. J Baghdad Coll Dent 2012;24:161-5.
7. Aljanabi ARA, Ghafour KM. Fuzzy AHP and fuzzy TOPSIS methods of analysing online impulsive buying of organic food: A cognitive-affective decision-making perspective. J Intell Fuzzy Syst 2024;2024(Preprint):1-16.
8. Al-Najjar HY. The Impact Of Severity Of Ischaemia In Acute Coronary Syndrome On The Extent Of Coronary Artery Disease At Angiography The Role Of Past Ischaemia. J Fac Med Baghdad 2006;48:236-243.
9. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Circulation 2018;138:e618-e651.
10. Urso C, Brucculeri S, Caimi G. Acid–base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart failure reviews. 2015;20:493-503.
11. Aziz F, Doddi S, Penupolu S, Del Castillo D, Raza W, Kallu S, et al. Prognostic implication of hyponatremia in setting of myocardial infarction. Chest 2011;140:986A.
12. Golledge J, Clancy P, Yeap BB, Hankey GJ, Norman PE. Increased serum angiopoietin-2 is associated with abdominal aortic aneurysm prevalence and cardiovascular mortality in older men. Int J Cardiol 2013;167:1159-63.
13. Wallner M, Khafaga M, Kolesnik E, Vafiadis A, Schwantzer G, Eaton DM, et al. Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium. Oncotarget 2017;8:49264.
14. Morici N, De Servi S, De Luca L, Crimi G, Montalto C, De Rosa R, et al. Management of acute coronary syndromes in older adults. Eur Heart J 2022;43:1542-1553.
15. Paneni F, Diaz Cañestro C, Libby P, Lüscher TF, Camici GG. The aging cardiovascular system: understanding it at the cellular and clinical levels. J Am Coll Cardiol 2017;69:1952-67.
16. Villar IC, Hobbs AJ, Ahluwalia A. Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor. J Endocrinol 2008;197:447-62.
17. Faraj HR. Clinical study of some electrolytes (sodium, chloride and potassium) with patients in acute coronary syndrome (ACS) in ThiQar Governorate, Iraq. Int J Curr Microbiol App Sci 2015;4:700-5.
18. Liu Y, Yao Y, Tang XF, Xu N, Jiang L, Gao Z, et al. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention. J Cardiol 2020;75:60-5.
19. Slywitch E, Savalli C, Duarte AC, Escrivao M. Obese Vegetarians and Omnivores Show Different Metabolic Changes: Analysis of 1340 Individuals. Nutrients 2022;14:2204.
20. Martinchik AN, Laikam KE, Kozyreva NA, Keshabyants EE, Mikhailov NA, Baturin AK, et al. [The prevalence of obesity in various socio-demographic groups of the population of Russia]. Vopr Pitan 2021;90:67-76.
21. Guo D, Zhang X, Zhan C, Lin Q, Liu J, Yang Q, et al. Sex Differences in the Association Between Obesity and Cognitive Impairment in a Low-Income Elderly Population in Rural China: A Population-Based Cross-Sectional Study. Front Neurol 2021;12:669174.
22. Dimeski G, Mollee P, Carter A. Effects of hyperlipidemia on plasma sodium, potassium, and chloride measurements by an indirect ion-selective electrode measuring system. Clin Chem 2006;52:155-6.
23. Raju KR, Sharifa A, Soumya P, Khanam R, Bhargav KkBS. Comparative study on the efficacy of statin therapy in lowering cholesterol and assessing the risk of metabolic syndrome in patients under statins therapy. Cell Mol Biomed Rep 2023;3:1-8.
24. Ishii S, Karlamangla AS, Bote M, Irwin MR, Jacobs Jr DR, Cho HJ, et al. Gender, obesity and repeated elevation of C-reactive protein: data from the CARDIA cohort. PloS one 2012;7:e36062.
25. WaliM V, Yatiraj S. Study of serum sodium and potassium in acute myocardial infarction. J Clin Diagn Res 2014;8:CC07-9.
26. Choi KH, Park MS, Kim JA, Lim JA. Associations between excessive sodium intake and smoking and alcohol intake among Korean men: KNHANES V. Int J Environ Res Public Health 2015;12:15540-9.
27. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005;26:1765-1773.
28. Aldaham S, Foote JA, Chow HH, Hakim IA. Smoking status effect on inflammatory markers in a randomized trial of current and former heavy smokers. Int J Inflam 2015:2015:439396.
29. Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen SJ, Weston SA, Meverden RA, et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 2005;111:295-301.
30. Turker Y, Ekinozu I, Turker Y, Akkaya M. High levels of high-sensitivity C-reactive protein and uric acid can predict disease severity in patients with mitral regurgitation. Rev Port Cardiol 2014;33:699-706.
Files | ||
Issue | Vol 62 No 6 (2024) | |
Section | Original Articles | |
Keywords | ||
Sodium Mitral regurgitation Acute coronary syndrome |
Rights and permissions | |
![]() |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |